SS

Sahil Sunil Adsul

Active Director Additional Director DIN 11297092
DIN 11297092 First appointment Sep 2025 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sahil Sunil Adsul

Data last updated:

Sahil Sunil Adsul is an Additional Director at Synthlife Pharma Private Limited (since 2025). The company operates in Paper.

DIN 11297092
Primary Designation Additional Director
Industry Paper
First Appointment 13 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synthlife Pharma Private Limited U21002PN2024PTC235858
Additional Director13 Sep 20252024Active

Board colleagues of Sahil Sunil Adsul

Directorship timeline

Open interactive timeline →
Synthlife Pharma Private Limited
Premium access

Shareholding and investment profile for Sahil Sunil Adsul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahil Sunil Adsul

Sahil Sunil Adsul currently holds 1 directorship: Synthlife Pharma Private Limited (Additional Director, since 13 Sep 2025).

Sahil Sunil Adsul was first appointed on 13 Sep 2025 as Additional Director at Synthlife Pharma Private Limited.

The current boards of Sahil Sunil Adsul's companies include Aparna Ashok Sawant (Synthlife Pharma Private Limited), Ashish Appasaheb Takawale (Synthlife Pharma Private Limited), Sharad Ashok Galave (Synthlife Pharma Private Limited), Yashraj Sanjay Sawant (Synthlife Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available